[go: up one dir, main page]

HK1114011A1 - 用於制备疫苗的方法 - Google Patents

用於制备疫苗的方法 Download PDF

Info

Publication number
HK1114011A1
HK1114011A1 HK08104083.2A HK08104083A HK1114011A1 HK 1114011 A1 HK1114011 A1 HK 1114011A1 HK 08104083 A HK08104083 A HK 08104083A HK 1114011 A1 HK1114011 A1 HK 1114011A1
Authority
HK
Hong Kong
Prior art keywords
saccharide
aliquot
minutes
carbodiimide
hours
Prior art date
Application number
HK08104083.2A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1114011C (zh
HK1114011B (zh
Inventor
Ralph Leon Biemans
Pierre Duvivier
Original Assignee
Glaxosmithkline Biologicals S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36716943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1114011(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB0513071.1A external-priority patent/GB0513071D0/en
Priority claimed from GBGB0513069.5A external-priority patent/GB0513069D0/en
Priority claimed from GB0515556A external-priority patent/GB0515556D0/en
Priority claimed from GB0524204A external-priority patent/GB0524204D0/en
Priority claimed from GB0526041A external-priority patent/GB0526041D0/en
Priority claimed from GB0526040A external-priority patent/GB0526040D0/en
Application filed by Glaxosmithkline Biologicals S.A. filed Critical Glaxosmithkline Biologicals S.A.
Publication of HK1114011A1 publication Critical patent/HK1114011A1/zh
Publication of HK1114011C publication Critical patent/HK1114011C/zh
Publication of HK1114011B publication Critical patent/HK1114011B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0017—Combination vaccines based on whole cell diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A61K39/0018—Combination vaccines based on acellular diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
    • A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16271—Demonstrated in vivo effect
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Surgical Instruments (AREA)
HK08104083.2A 2005-06-27 2006-06-23 用於制备疫苗的方法 HK1114011B (zh)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
GBGB0513071.1A GB0513071D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GB0513071.1 2005-06-27
GBGB0513069.5A GB0513069D0 (en) 2005-06-27 2005-06-27 Immunogenic composition
GB0513069.5 2005-06-27
GB0515556A GB0515556D0 (en) 2005-07-28 2005-07-28 Immunogenic composition
GB0515556.9 2005-07-28
GB0524204A GB0524204D0 (en) 2005-11-28 2005-11-28 Immunogenic composition
GB0524204.5 2005-11-28
GB0526041A GB0526041D0 (en) 2005-12-21 2005-12-21 Immunogenic composition
GB0526041.9 2005-12-21
GB0526040A GB0526040D0 (en) 2005-12-21 2005-12-21 Immunogenic composition
GB0526040.1 2005-12-21
PCT/EP2006/006270 WO2007000343A2 (en) 2005-06-27 2006-06-23 Process for manufacturing vaccines

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK11108230.0A Division HK1153679A (zh) 2005-06-27 2008-04-10 用於制备疫苗的方法

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK11108230.0A Addition HK1153679A (zh) 2005-06-27 2008-04-10 用於制备疫苗的方法

Publications (3)

Publication Number Publication Date
HK1114011A1 true HK1114011A1 (zh) 2008-10-24
HK1114011C HK1114011C (zh) 2011-10-28
HK1114011B HK1114011B (zh) 2011-10-28

Family

ID=

Also Published As

Publication number Publication date
IL188046A (en) 2012-03-29
KR20080018216A (ko) 2008-02-27
PT2351578T (pt) 2017-04-07
PT3009146T (pt) 2021-11-30
NZ590204A (en) 2012-02-24
US20150044253A1 (en) 2015-02-12
IL187924A0 (en) 2008-03-20
PT1896065E (pt) 2011-08-31
JP2008543908A (ja) 2008-12-04
JP5718960B2 (ja) 2015-05-13
IL222346A (en) 2015-07-30
CN102526723B (zh) 2017-07-07
EP1896066B8 (en) 2022-01-19
LTPA2012019I1 (lt) 2012-11-26
UA95237C2 (uk) 2011-07-25
PT1896062E (pt) 2010-05-17
IL213718A0 (en) 2011-07-31
CY1111827T1 (el) 2015-10-07
EA200702577A1 (ru) 2008-06-30
CA2611960A1 (en) 2007-01-04
US20080193476A1 (en) 2008-08-14
SI1896063T1 (sl) 2012-03-30
JP2008543907A (ja) 2008-12-04
HUE031380T2 (en) 2017-07-28
WO2007000314A3 (en) 2007-05-31
JP2008543905A (ja) 2008-12-04
CY1118646T1 (el) 2017-07-12
KR20130086087A (ko) 2013-07-30
CA2612963C (en) 2016-10-18
DE602006013313D1 (de) 2010-05-12
EA012528B1 (ru) 2009-10-30
EA200702574A1 (ru) 2008-06-30
AR056397A1 (es) 2007-10-10
KR20080025184A (ko) 2008-03-19
NO344452B1 (no) 2019-12-09
NO20076363L (no) 2008-03-26
MA29993B1 (fr) 2008-12-01
EA200702575A1 (ru) 2008-06-30
EP1896065B1 (en) 2011-07-20
FR22C1008I2 (fr) 2024-01-19
PE20142165A1 (es) 2015-01-09
US20170065714A1 (en) 2017-03-09
KR101321056B1 (ko) 2013-10-30
MX2007016403A (es) 2008-03-07
DK2283857T3 (da) 2019-10-28
DK2351578T3 (en) 2017-04-24
CA2611964A1 (en) 2007-01-04
HRP20100211T1 (hr) 2010-05-31
PE20070123A1 (es) 2007-02-08
MY147783A (en) 2013-01-31
PL2283857T3 (pl) 2020-02-28
IL188072A (en) 2017-07-31
PE20070163A1 (es) 2007-03-01
KR20130122810A (ko) 2013-11-08
NO345305B1 (no) 2020-12-07
AU2010203115A1 (en) 2010-08-12
CA2612957A1 (en) 2007-01-04
BRPI0612669B8 (pt) 2021-05-25
EP1896065B2 (en) 2014-09-03
EA013374B1 (ru) 2010-04-30
HK1116414A1 (zh) 2008-12-24
JP5037503B2 (ja) 2012-09-26
CN103083657A (zh) 2013-05-08
EP3009146A1 (en) 2016-04-20
US20200000911A1 (en) 2020-01-02
JP5731737B2 (ja) 2015-06-10
JP5280199B2 (ja) 2013-09-04
HK1206587A1 (zh) 2016-01-15
LT2351578T (lt) 2017-04-10
HUS2200002I1 (hu) 2022-12-28
DK2878307T3 (da) 2019-10-07
EP3009146B1 (en) 2021-10-20
NO342815B1 (no) 2018-08-13
KR101532068B1 (ko) 2015-06-29
ES2901378T3 (es) 2022-03-22
SI2283857T1 (sl) 2019-11-29
WO2007000342A3 (en) 2007-05-31
US8431136B2 (en) 2013-04-30
BRPI0612670B8 (pt) 2021-05-25
AR056396A1 (es) 2007-10-10
SI1896065T1 (sl) 2011-10-28
TWI537001B (zh) 2016-06-11
TW200730187A (en) 2007-08-16
SI1896061T1 (sl) 2019-10-30
DK1896063T3 (da) 2012-03-19
PT2283857T (pt) 2019-10-24
IL213795A (en) 2013-05-30
EP1896062A1 (en) 2008-03-12
ES2621780T3 (es) 2017-07-05
FR22C1008I1 (fr) 2022-04-29
NL301151I2 (nl) 2025-12-15
MA29569B1 (fr) 2008-06-02
UA95238C2 (uk) 2011-07-25
PL3009146T3 (pl) 2022-02-07
KR101351873B1 (ko) 2014-02-17
US20190298822A1 (en) 2019-10-03
CY2012027I1 (el) 2015-10-07
KR101351870B1 (ko) 2014-02-17
HK1116413A1 (zh) 2008-12-24
KR20080018226A (ko) 2008-02-27
CA2611964C (en) 2016-11-08
PL1896061T3 (pl) 2020-02-28
EP2351578A1 (en) 2011-08-03
HUE046905T2 (hu) 2020-03-30
IL214657A0 (en) 2011-09-27
PL1896063T3 (pl) 2012-04-30
US8329184B2 (en) 2012-12-11
MX2007016402A (es) 2008-03-07
NO345422B1 (no) 2021-01-25
BRPI0612670B1 (pt) 2020-04-28
US10166287B2 (en) 2019-01-01
AU2010203115C1 (en) 2013-05-02
WO2007000343A2 (en) 2007-01-04
HUS1200023I1 (hu) 2021-03-29
EP1896063B2 (en) 2016-03-02
AP2436A (en) 2012-08-31
EP1896061B1 (en) 2019-06-12
BRPI0612656B1 (pt) 2021-09-08
US8846049B2 (en) 2014-09-30
ATE516816T1 (de) 2011-08-15
LUC00247I2 (zh) 2024-10-04
US8398983B2 (en) 2013-03-19
MX2007016236A (es) 2008-03-07
BRPI0612654B1 (pt) 2021-05-04
PL1896062T3 (pl) 2010-08-31
ATE462444T1 (de) 2010-04-15
EA200702576A1 (ru) 2008-06-30
AU2006263944A1 (en) 2007-01-04
US9789179B2 (en) 2017-10-17
ES2377075T3 (es) 2012-03-22
US20090136541A1 (en) 2009-05-28
WO2007000322A1 (en) 2007-01-04
ES2340711T3 (es) 2010-06-08
ES2662651T3 (es) 2018-04-09
HUS000497I2 (hu) 2021-03-29
EP2878307A1 (en) 2015-06-03
AU2006263963A1 (en) 2007-01-04
NO20076343L (no) 2008-03-25
WO2007000342A2 (en) 2007-01-04
IL188072A0 (en) 2008-03-20
US20130004532A1 (en) 2013-01-03
CA2612963A1 (en) 2007-01-04
PE20110096A1 (es) 2011-03-07
US20080199490A1 (en) 2008-08-21
CN103083657B (zh) 2016-06-08
CA2612980A1 (en) 2007-01-04
US20090252759A1 (en) 2009-10-08
DK1896061T3 (da) 2019-08-26
WO2007000327A1 (en) 2007-01-04
PL1896065T3 (pl) 2011-12-30
ES2750243T3 (es) 2020-03-25
NO20076302L (no) 2008-03-26
PL2878307T3 (pl) 2020-01-31
US20090041802A1 (en) 2009-02-12
WO2007000314A2 (en) 2007-01-04
HUE045482T2 (hu) 2019-12-30
HUE047211T2 (hu) 2020-04-28
JP2008543909A (ja) 2008-12-04
NZ564607A (en) 2011-06-30
TW201414490A (zh) 2014-04-16
US9931397B2 (en) 2018-04-03
CN102218138A (zh) 2011-10-19
CY1109996T1 (el) 2014-09-10
CA2612957C (en) 2016-07-19
IL213718A (en) 2013-07-31
JP5297800B2 (ja) 2013-09-25
AU2006263964A1 (en) 2007-01-04
EP2283857B1 (en) 2019-07-24
KR101359953B1 (ko) 2014-02-21
US9358279B2 (en) 2016-06-07
TW201336507A (zh) 2013-09-16
MX2007016405A (es) 2008-03-07
LU92085I2 (fr) 2012-12-19
SI2878307T1 (sl) 2019-11-29
NZ564606A (en) 2010-10-29
PE20110072A1 (es) 2011-02-04
MA29603B1 (fr) 2008-07-01
JP5965512B2 (ja) 2016-08-03
AU2006263963B2 (en) 2010-05-13
US10245317B2 (en) 2019-04-02
EP2201961B1 (en) 2018-01-24
PE20070499A1 (es) 2007-05-21
CA2612980C (en) 2019-01-15
PL1896065T5 (pl) 2014-12-31
EP2201961A1 (en) 2010-06-30
AU2006263965A1 (en) 2007-01-04
NO20076350L (no) 2008-03-26
EP1896063A1 (en) 2008-03-12
AU2006263964B2 (en) 2010-05-20
SI3009146T1 (sl) 2022-02-28
ATE536884T1 (de) 2011-12-15
MA29602B1 (fr) 2008-07-01
US20180064806A1 (en) 2018-03-08
HRP20110567T1 (en) 2011-09-30
DK1896065T3 (da) 2011-08-29
JP2013209395A (ja) 2013-10-10
ES2741529T3 (es) 2020-02-11
BRPI0612669A2 (pt) 2010-11-30
BRPI0612656A8 (pt) 2018-01-23
WO2007000343A3 (en) 2007-05-31
ES2747025T3 (es) 2020-03-09
JP2015134829A (ja) 2015-07-27
AU2006263936B2 (en) 2010-05-20
HRP20170457T1 (hr) 2017-05-19
WO2007000342A8 (en) 2008-07-10
AP2007004274A0 (en) 2007-12-31
DK1896062T3 (da) 2010-06-28
BE2012C042I2 (zh) 2021-07-19
NZ564371A (en) 2010-05-28
AU2006263936A1 (en) 2007-01-04
US9486515B2 (en) 2016-11-08
HRP20110567T4 (xx) 2015-01-16
EP1896061A2 (en) 2008-03-12
PT1896061T (pt) 2019-08-01
TWI422386B (zh) 2014-01-11
SI2351578T1 (sl) 2017-05-31
HRP20120102T1 (hr) 2012-02-29
WO2007000341A3 (en) 2007-05-31
NZ564370A (en) 2011-10-28
PT2878307T (pt) 2019-10-24
BRPI0612656A2 (pt) 2010-11-30
BRPI0612654A2 (pt) 2012-10-02
BRPI0612669B1 (pt) 2019-08-13
KR20080024222A (ko) 2008-03-17
AU2010212417A1 (en) 2010-09-09
CN102526723A (zh) 2012-07-04
EA012214B1 (ru) 2009-08-28
LU92085I9 (zh) 2019-01-04
EP2283857A1 (en) 2011-02-16
EP1896063B1 (en) 2011-12-14
JP2008543904A (ja) 2008-12-04
IL187924A (en) 2011-11-30
IL213795A0 (en) 2011-07-31
US20100215686A1 (en) 2010-08-26
AU2006263944B2 (en) 2012-03-01
TW200738259A (en) 2007-10-16
MX2007016237A (es) 2008-03-07
DK1896065T4 (da) 2014-10-20
US20130171188A1 (en) 2013-07-04
EP1896062B1 (en) 2010-03-31
EP1896064A2 (en) 2008-03-12
SI1896062T1 (sl) 2010-07-30
NZ564605A (en) 2011-01-28
IL188046A0 (en) 2008-03-20
IL188045A0 (en) 2008-03-20
TWI477283B (zh) 2015-03-21
BRPI0612654B8 (pt) 2021-05-25
JP2013018798A (ja) 2013-01-31
MY147490A (en) 2012-12-14
KR20080030577A (ko) 2008-04-04
AU2010203115B2 (en) 2012-03-15
BRPI0612655B1 (pt) 2021-06-15
US11241495B2 (en) 2022-02-08
ES2377075T5 (es) 2016-04-29
US8883163B2 (en) 2014-11-11
TWI407970B (zh) 2013-09-11
JP2013107913A (ja) 2013-06-06
AU2006263965B2 (en) 2012-09-13
EP1896066B1 (en) 2021-10-27
PL2351578T3 (pl) 2017-07-31
CY2012027I2 (el) 2015-10-07
ES2898451T3 (es) 2022-03-07
PT1896063E (pt) 2012-02-13
EP2878307B1 (en) 2019-07-24
BRPI0612655A8 (pt) 2018-01-30
EP1896066A2 (en) 2008-03-12
LTC1896065I2 (lt) 2025-06-10
WO2007000341A2 (en) 2007-01-04
HUE056842T2 (hu) 2022-03-28
BRPI0612655A2 (pt) 2010-11-30
CY1112698T1 (el) 2016-02-10
MY148110A (en) 2013-02-28
KR101408113B1 (ko) 2014-06-16
NL300549I2 (zh) 2017-01-03
EP1896065A2 (en) 2008-03-12
SI1896065T2 (sl) 2014-12-31
AR053935A1 (es) 2007-05-23
EP2351578B1 (en) 2017-01-18
BRPI0612670A2 (pt) 2010-11-30
JP5769688B2 (ja) 2015-08-26
CA2611960C (en) 2015-05-05
EA012506B1 (ru) 2009-10-30

Similar Documents

Publication Publication Date Title
EP1896065B1 (en) Process for manufacturing vaccines
US20090311285A1 (en) Vaccine
ES2367918T3 (es) Procedimiento de fabricación de vacunas.
HK1114011C (zh) 用於製備疫苗的方法
HK1114011B (zh) 用於制备疫苗的方法
HK1153679A (zh) 用於制备疫苗的方法
HK1206587B (zh) 免疫原性组合物
CN101208102A (zh) 免疫原性组合物
HK1116412B (zh) 免疫原性组合物
HK1116082A (zh) 免疫原性组合物
HK1116082B (zh) 免疫原性组合物

Legal Events

Date Code Title Description
AM43 Amendment of standard patent following opposition or revocation proceedings in the designated patent office (acc. sect 43 patent ordinance)